• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

mHealth (Mobile Health)

Voluntis, WellDoc partner to offer digital diabetes management system

January 16, 2018 By Sarah Faulkner

Voluntis Insulia

Voluntis has inked a commercial deal to combine its insulin titration tech with WellDoc‘s coaching platform to create a digital management solution for people with Type II diabetes. Cambridge, Mass.-based Voluntis has developed an FDA-approved system, Insulia, which provides automated insulin dose recommendations that can be monitored remotely by a patient’s healthcare team. WellDoc’s BlueStar […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals Tagged With: Voluntis, welldoc

Dexcom posts cautious 2018 forecast despite Street-beating Q4, FY17 prelims

January 9, 2018 By Sarah Faulkner

Dexcom

Dexcom (NSDQ:DXCM) shares fell today after the company issued conservative guidance for its expected revenue in 2018. The company also posted Street-beating preliminary results for its fourth quarter and full-year 2017 revenues. The company is facing competition in the new year after the FDA approval of Abbott‘s (NYSE:ABT) continuous glucose monitor, the FreeStyle Libre. But chief executive […]

Filed Under: Featured, MassDevice Earnings Roundup, mHealth (Mobile Health), Patient Monitoring, Wall Street Beat Tagged With: abbott, DexCom Inc.

Pear Therapeutics raises $50m for digital substance use disorder therapies

January 2, 2018 By Sarah Faulkner

Pear Therapeutics

Pear Therapeutics said today that it closed a $50 million Series B round to help commercialize its prescription digital substance abuse therapies. Temasek led the round and was joined by 5AM Ventures, Jazz Venture Partners, Novartis (NYSE:NVS) and others. In September, the company’s reSET therapy became the first prescription digital therapeutic approved by the FDA. One […]

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals Tagged With: Novartis, peartherapeutics

BioCorp’s smart cap wins CE Mark for insulin pen

December 20, 2017 By Sarah Faulkner

Biocorp

Biocorp (PAR:ALCOR) said today that its smart cap, Easylog, won CE Mark clearance for use with insulin delivery devices. The company’s device turns traditional pen injectors into connected devices, capturing treatment information like dose, date and time of injection. Easylog transfers that data to a mobile app for patients to monitor. “CE marking for Easylog is […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: biocorp

5 tips for developing a connected drug-delivery device

December 19, 2017 By Sarah Faulkner

Sunrise labs

Now more than ever, people are carrying their computers at their fingertips and managing nearly every aspect of their lives online – including their health. Meanwhile, the medtech and pharmaceutical industries are looking for ways to help people stay on top of their treatment regimens and improve outcomes. Many companies believe that by combining their […]

Filed Under: Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Research & Development Tagged With: sunriselabs

Companion Medical launches smart insulin pen in U.S.

December 14, 2017 By Sarah Faulkner

Companion Medical

Companion Medical started selling its smart insulin pen in the U.S. today, according to the San Diego, Calif.-based company. The InPen system, which combines an insulin injector pen and a smartphone app, is compatible with Eli Lilly‘s (NYSE:LLY) Humalog and Novo Nordisk‘s (NYSE:NVO) Novolog fast-acting insulin. Companion Medical’s InPen tracks insulin dosing, automatically sending data […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals Tagged With: Companion Medical, Eli Lilly & Co., Novo Nordisk

Medtech stories we missed this week: Nov. 17, 2017

November 17, 2017 By Danielle Kirsh

missed medtech

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Implants, mHealth (Mobile Health), Neurological, Regulatory/Compliance, Research & Development Tagged With: Helomics, InnerScope, iReliev, LensAR Inc., medtech, Mevion Medical Systems, Mortise Medical, Nexstim, Skyline Medical

Medtech stories we missed this week: Sept. 22, 2017

September 22, 2017 By Danielle Kirsh

missed-medtech-0922

From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Hospital Care, mHealth (Mobile Health), Regulatory/Compliance, Research & Development Tagged With: Bioventus LLC, Contego Medical, Covalon Technologies, Getinge, Guerbet, IBA, ManaMed, medovex, medtech

Nemaura develops medical grade diabetes management app

August 29, 2017 By Sarah Faulkner

Nemaura Medical

Nemaura Medical (OTC:NMRD) said today that it has finished development of a medical grade app designed to be used with the company’s SugarBeat continuous glucose monitoring system or with glucose meters. The mobile app, which was developed for android mobile devices, allows users to input their diet, medication and exercise information, as well as view […]

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Research & Development, Wall Street Beat Tagged With: Nemaura Medical

7 diagnostic devices to boost healthcare in the developing world

August 16, 2017 By Danielle Kirsh

Diagnostic-Devices-Developing-World-MD

The World Health Organization estimates that a quarter of death and disease globally is caused by hazards and environmental burdens in developing countries with little to no access to preventative care and diagnostic devices. Since developing countries are poor agricultural regions that are still becoming economically and socially advanced, it is harder for doctors to […]

Filed Under: Diagnostics, Featured, mHealth (Mobile Health), Research & Development Tagged With: Binghamton University, centrifuge, diagnostic devices, Massachusetts Institute of Technology, medtech, North Carolina State University, Stanford University, University of Illinois at Urbana-Champaign, University of North Carolina at Chapel Hill

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS